Medpage Today on MSN1mon
Taking on Acquired Resistance in EGFR-Mutant NSCLCthe next line of standard care is to give another EGFR-targeting agent in combination with chemotherapy, Burns said: "In this ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback